Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001609970-15-000003
Filing Date
2015-07-30
Accepted
2015-07-29 19:39:28
Documents
1
Effectiveness Date
2015-07-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8618
  Complete submission text file 0001609970-15-000003.txt   9753
Mailing Address 4225 EXECUTIVE SQUARE, STE. 960 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE, STE. 960 LA JOLLA CA 92037 (858) 356-7338
Laguna Pharmaceuticals, Inc. (Filer) CIK: 0001609970 (see all company filings)

IRS No.: 263084202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-244746 | Film No.: 151014051